Orchestra BioMed Holdings, Inc. (OBIO): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$49.45M
Year ended 2025-12-31
-$59.10M
Trailing 12 months to 2026-06-30
2022-12-31: -$29.88M2023-12-31: -$46.20M2024-12-31: -$50.85M2025-12-31: -$49.45M-$49.45M
2022-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$49.45Mn/m2026-03-12, From 2025-01-01
2024-12-31-$50.85Mn/m2026-03-12, From 2024-01-01
2023-12-31-$46.20Mn/m2025-03-31, From 2023-01-01
2022-12-31-$29.88Mn/a2024-03-27, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$49.45Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.40Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$24.45Mn/m
Cytosorbents Corp (CTSO)2025-12-31-$12.54Mn/m
Retractable Technologies Inc (RVP)2024-12-31-$13.00Mn/m
Utah Medical Products Inc (UTMD)2025-12-31$14.32M-1.9%
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.47M+45.2%
Sensus Healthcare, Inc. (SRTS)2025-12-31$332.0Kn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$470.1Kn/m

Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗